Screener
Inhibikase Therapeutics, Inc. IKT Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.11Miss by $0.02
EPS estimate-$0.09
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.11
Versus estimates
Diluted EPS
FAQ
- When did Inhibikase Therapeutics, Inc. report Q2 2025 earnings?
- Inhibikase Therapeutics, Inc. (IKT) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Inhibikase Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Inhibikase Therapeutics, Inc. reported eps of $-0.11 for Q2 2025.
- Did Inhibikase Therapeutics, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.09 by $0.02.
- How did Inhibikase Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 83.3% from $-0.66.
- Where can I find Inhibikase Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-180889) and the 10-Q periodic report (0001193125-25-180899) directly on SEC EDGAR. The filing index links above go to sec.gov.
